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REVIEW
The Status of Irritability in Psychiatry: A Conceptual and
Quantitative Review
Pablo Vidal-Ribas, MSc, Melissa A. Brotman, PhD, Isabel Valdivieso, MSc,
Ellen Leibenluft, MD, Argyris Stringaris, MD, PhD, MRCPsych
Objective: Research and clinical interest in irritability
have been on the rise in recent years. Yet several questions
remain about the status of irritability in psychiatry,
including whether irritability can be differentiated from
other symptoms, whether it forms a distinct disorder, and
whether it is a meaningful predictor of clinical outcomes.
In this article, we try to answer these questions by
reviewing the evidence on how reliably irritability can be
measured and its validity.
Method: We combine a narrative and systematic review
and meta-analysis of studies. For the systematic review
and meta-analysis, we searched studies in PubMed and
Web of Science based on preselected criteria. A total of
163 articles were reviewed, and 24 were included.
Results: We found that irritability forms a distinct
dimension with substantial stability across time, and that
it is speciﬁcally associated with depression and anxiety in
longitudinal studies. Evidence from genetic studies
reveals that irritability is moderately heritable, and its
overlap with depression is explained mainly by genetic
factors. Behavioral and neuroimaging studies show that
youth with persistent irritability exhibit altered activations
in the amygdala, striatum, and frontal regions compared
with age-matched healthy volunteers. Most knowledge
about the treatment of irritability is based on effects of
treatment on related conditions or post hoc analyses of
trial data.
Conclusion: We identify a number of research priorities
including innovative experimental designs and priorities
for treatment studies, and conclude with recommenda-
tions for the assessment of irritability for researchers and
clinicians.
Key words: irritability, depression, anxiety, conduct,
meta-analysis
J Am Acad Child Adolesc Psychiatry 2016;55(7):556–570.
I rritability describes proneness to anger.
1 As many other
psychiatric concepts, before it entered nosology, it was
the domain of poets,2,3 philosophers,4,5 and theologians.6
It was featured in Burton’s concept of melancholia,7 and it
was termed “krankhafte Reizbarkeit” (literally, pathological
irritability) in Bleuler’s textbook of psychiatry.8 It also has a
venerable history in psychoanalysis, self-directed hostility
underlying what Freud described as “the undoubtedly
pleasurable self-torture of melancholy.”9
Irritability was omnipresent in all recent versions of the
DSM as a symptom of psychiatric disorders and is, along-
side lack of concentration and restlessness, one of the few
symptoms to cut across externalizing and internalizing dis-
orders.10 Chronic severe irritability as the primary feature of
a new diagnostic category was introduced in the DSM-5 in
response to the controversy regarding the debate over the
diagnosis of bipolar in children.11,12 Over the last 10 to
15 years, the number of prepubertal children diagnosed with
bipolar disorder (BD) in the United States has increased
at rates close to 500%.13,14 This increase was thought to result
partly from counting severe and chronic irritability of early
onset (“present forever” or “since the ﬁrst year of life”) as a
cardinal manic symptom, analogous to the classical cardinal
manic symptoms of elated mood or episodic irritability.12
The diagnosis of disruptive mood dysregulation disorder
(DMDD)10 was an attempt to curb what was seen as an
overdiagnosis of BD, while recognizing the burden of
problems suffered by children whose primary problem was
chronic severe irritability, for whom there was no diagnostic
home in the DSM.
In the Research Domain Criteria (RDoC) framework,15
irritability is regarded as an expression of frustrative non-
reward, which is deﬁned as the reaction to blocked goal
attainment. Conceptualizing irritability as a response to blocked
goal attainment allows for research across species. Moreover,
seeing irritability as a dimension is in line with a broader
recognition within psychiatry that phenotypes may lie on a
quantitative spectrum rather than being discrete categories.16
The introduction into DSM of chronic severe irritability as
a nosological category of its own has led to inevitable ques-
tions about its conceptual foundations as well as about its
reliability and validity. In this review, we set out to answer
those questions. We start by providing a conceptual back-
ground about irritability, offering a working deﬁnition and
delineating its relationship to key concepts such as reward,
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emotion, mood, aggression, and normal variations in
behavior. We then set out to address questions about reli-
ability and validity. We do so guided by both the Robins-Guze
criteria17 and the Cronbach and Mehl validity consider-
ations.18 We ﬁrst examine whether irritability forms a statis-
tically distinct factor, before looking at how reliably it can be
measured across time and informants. After that, we present
the results of a systematic review and meta-analysis about the
longitudinal predictions of irritability. We then turn to its
etiological underpinnings by examining the available genetic
and neuroimaging literature. We conclude with a discussion
of our ﬁndings and delineate several research priorities.
WORKING DEFINITION AND CONCEPTUAL
BACKGROUND
Irritability refers to interindividual differences in proneness
to anger that may reach a pathological extent. We deliber-
ately use this broad deﬁnition as it allows us to discuss the
boundaries of irritability, for example, issues about whether
such reactions are normative (see deﬁnition published else-
where19) or whether a behavioral component such as
aggression is required (see elsewhere, for example20). In
keeping with Karl Popper, the philosopher of science, we see
the role of a deﬁnition as “cutting a long story short” rather
than as condensing all knowledge on the subject. As in all
other areas of science, the deﬁning terms are in themselves
hard to deﬁne—neither “proneness” nor “anger” are
semantically unequivocal. Below we explore such terms
related to irritability in an attempt to prevent what has been
described as “quarrelling about words.”21
Feelings, Emotions, Mood, Affect, and Irritability
It is useful both clinically and for the design of future
experimental studies to discuss the relationship between ir-
ritability and the key concepts of feeling, emotion, mood,
and affect.
Anger, the deﬁning feature of irritability, can be
conceptualized as a feeling but also as an emotion. Anger is
a feeling in that individuals are consciously aware of a set
of thoughts and bodily sensations that they describe as
anger. Similarly, an individual may sense a proneness to
anger as feeling on edge or feeling touchy—another
description for feeling irritable. On the other hand, emo-
tions are thought of as action tendencies that do not need to
enter conscious awareness, although they may do so.
Anger can be an emotion in that people may act in an angry
way without being aware of it (i.e., without feeling the
anger). Experimentally, this is demonstrated through the
subliminal presentation of stimuli and assessment of
the participants’ response biases.22 The concept of mood is
used by clinicians to describe states that are valenced
(i.e., negative as in depression or positive as in mania) and
enduring. How enduring such a state has to be in order to
be called a mood rather than an emotion is, however, un-
clear. Also, although emotions are evoked responses to
stimuli, the deﬁnition of mood does not entail a stimulus.
Irritability is a mood in the sense that young people can
remain in states of proneness to anger for very long times
and sometimes for no apparent reason, as discussed below.
Typically psychiatrists assess mood by accessing their pa-
tient’s feelings, although clinicians will also resort to de-
scriptions of patients by others, such as when asking
parents to rate their child’s irritability. Finally, in psychia-
try, the term “affect” describes the observed features of a
mood or emotion, such as angry facial expression in
someone who is irritable during interview.
In summary, irritability is a mood, and anger is its
deﬁning emotion. When anger enters the person’s aware-
ness, it is called a feeling, and when observable to others,
such as clinicians, anger is described as an affect. The
reader should interpret these statements cautiously
because the boundaries between the concepts of mood and
emotion are not ﬁrmly grounded in empirical data and
because in a lot of the literature, mood and emotion are
used synonymously.
The Phasic and Tonic Components of Irritability
An alternative clinical conceptualization of irritability is pre-
sented in the DSM-5 and derives from the work of Leibenluft
et al. deﬁning the syndrome of severe mood dysregulation
(SMD), the precursor to DMDD.12,23 The DSM-5 criteria for
DMDD identify 2 components of irritability. Phasic irritability
refers to developmentally inappropriate temper outbursts,
whereas tonic irritability refers to the negative affect that
persists between outbursts. These 2 components were
included in SMD because the temper outbursts are the hall-
mark clinical feature of these children, whereas requiring the
tonic component allowed the investigators to recruit a sample
of children who, like those with BD, have a severe and
persistent mood disorder. The latter was important because
SMD was operationalized to compare youth with chronic,
persistent, severe irritability (i.e., the SMD phenotype) to
youth who have distinct manic episodes characterized by
elated mood (i.e., classic BD). However, it is unclear whether
tonic and phasic irritability are distinct constructs in terms of
validators such as longitudinal clinical predictions, treatment
response, pathophysiology, or family history. The 2 con-
structs are difﬁcult to distinguish in secondary analyses of
epidemiological data,24 yet the distinction needs to be tested
in clinical data using instruments speciﬁcally designed to
capture each component. The DSM-5 account of irritability
has the advantage of being purely descriptive and not having
to resort to concepts such as emotion or mood that are hard to
deﬁne in their own right.
Approach Tendencies, Reward, and Irritability
Irritability and its deﬁning feeling of anger are classiﬁed as
negatively valenced and therefore, by deﬁnition, as un-
pleasant, as with fear or sadness. However, although people
typically avoid fear-inducing stimuli, people will approach
anger-inducing stimuli in experimental paradigms.22 More-
over, people who score high on angry traits are also more
likely to score highly on behavioral approach tendencies and
the seeking of rewards.25 This unique position of irritability
among emotional valence and approach/avoidance ten-
dencies, as described by Stringaris and Taylor,1 is depicted
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in Figure 1. Indeed, irritability has been linked with the
frustration that arises when a goal is blocked.26 Such a goal
may be strictly deﬁned (e.g., being prevented from obtaining
a promised monetary reward) or may be more complex and
embedded within social relationships (e.g., experiencing an
insult or similar social setback). The clinical equivalent of
what experimental psychologists describe as an approach
tendency may be the propensity to ﬁght (literally or meta-
phorically) to obtain a blocked response. In such situations,
irritability has 2 effects. First, it reﬂects the motivation
behind continued attempts to obtain the reward. Second, a
child’s irritability can evoke negative feelings in parents or
peers—these feelings may range from fear and avoidance (or
accommodation in the case of the parents) to mutual feelings
of anger. In that sense, irritability can be a potent
environment-modifying emotion. Relationships between
parents and children that are characterized by irritability
have been described as mutually coercive27 and are the
target of parenting interventions.
Irritability and Aggression
Verbal or physical aggression is often the trigger for referring
irritable youth to mental health services.28 Yet irritability is
by no means the same thing as aggression. Shouting or
ﬁghting (parts of the deﬁnition of aggression) can arise out of
escalated anger; however, irritable children may simply be
grumpy, hufﬁng and pufﬁng, or experiencing burdensome
dysphoria (“stewing inside”), rather than exhibiting aggres-
sion. Separating irritability from aggression is therefore
important for 2 reasons: ﬁrst, because recognizing it might
prevent the manifestation of aggression; second, because ir-
ritability may be burdensome independent of aggressive acts.
Boundaries to Normality and Dysregulation
Anger can be a normal reaction1 and can vary along with
other temperamental traits29; it can also predict signiﬁcant
impairment throughout life.19,30 Deciding where to set the
threshold above which irritability would be considered
pathological can be difﬁcult and may vary, depending on
factors such as the young person’s age or environment.
Because clinicians must make binary decisions (“to treat or
not to treat”), having a threshold is important. However,
such cut-offs are often arbitrary, and, as we shall see below,
this arbitrariness may have a negative impact upon reli-
ability and validity. It is possible to derive empirical
thresholds, for example, deﬁning levels of irritability based
on the amount of associated impairment.
The term “dysregulation”—frequently used to describe
irritability (as, for example, in DMDD)—entails a judgment
about what is pathological. Irritability is one of many man-
ifestations of mood dysregulation.
With these discussions about normativity in mind, it is
not surprising that estimates of the prevalence of irritability
can vary substantially. For example, lifetime prevalence of
SMD was observed to be about 3.3% in children and ado-
lescents aged 9 to 19 years.31 The rates of DMDD were
similar (3.3%) in a sample of preschool children.32 However,
these rates decreased to 1% in 2 samples of older youth.32
Studies examining mood dysregulation and mood lability,
which includes irritability as 1 of its manifestations, have
reported higher prevalence estimates. In community studies,
5% to 6% of youth aged 8 to 19 had a lot of mood lability,33
and 3.8% of youth aged 4 to 16 years presented with the
Child Behavior Checklist (CBCL) Dysregulation pheno-
type,34 which is linked to irritability. Finally, about 20% of
adolescents participating in the Isle of Wight study35 were
rated as displaying signiﬁcant irritability in terms of fre-
quency, severity, and duration.
MULTIVARIATE
Speciﬁc Question: Does irritability form a factor that can be
distinguished from other psychiatric constructs in multi-
variate statistical analysis?
The application of factor analysis as a method of
construct validation has a long history in the development of
psychological constructs18 and has also been used to validate
irritability.
Irritability, operationalized as touchiness, easy annoy-
ance, and anger, was shown to have differential predictions
compared to other symptoms of oppositional deﬁant disor-
der (ODD), such as deﬁance or vindictiveness.36 This ﬁnding
prompted a series of either exploratory factor analyses
(where no speciﬁc hypothesis is being tested),37 or conﬁr-
matory factor analyses.37-41 These published analyses
demonstrate that irritability is a distinguishable dimension
within ODD. Importantly, some of these articles have shown
the superiority of considering irritability41 as an independent
dimension over several other alternative models.42,43 A
recent comprehensive analysis of 5 different samples
compared a variety of models and concluded that an irrita-
ble dimension deﬁned as anger, temper outburst, and easy
annoyance36 ﬁt the data best.39
The independence of irritability as a construct has also
been conﬁrmed using latent class analysis.40,44-46 Unlike factor
analysis, which examines dimensions within the data, this
method aims to identify groups of people based on their
response to a questionnaire, for example.47 This method,
therefore, is closer to the binary constructs that clinicians use.
Conclusion: In both factor and latent class analyses, irri-
tability can be differentiated from other symptoms of
FIGURE 1 The position of irritability within commonly used
terminology. Note: irritability shares a negative valence with
anxiety and depression but denotes approach and is therefore
linked to elation in mania.
Mood dysregulation
Negative valence Positive valence
Fear Sadness Irritability Elation
Withdrawal Approach
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oppositional behavior; however, its distinctiveness from
other items of psychopathology has yet to be demonstrated.
RELIABILITY
Speciﬁc Question: Can irritability be measured reliably?
The word “reliable” here refers to whether a measure
yields consistent results across different conditions or time
points.18 Height measurements are a prototype of reliable
measurements of physical health, and IQ measurements are
also consistent, at least after a certain age.48 Reliable mea-
surement of a psychological construct, such as irritability, is
a prerequisite for testing its validity (i.e., testing whether the
measure captures what it is purporting to be measuring).
The reliability of irritability has been assessed in the
following ways:
Internal Consistency. This assesses how well items of a
scale correlate with each other. The average internal con-
sistency of irritability scales is high (a ¼ 0.75),19,37,40,49-53
ranging from 0.49 (for ad hoccreated scales)19 to 0.92 (for
speciﬁcally developed irritability scales).50
TestRetest Reliability (or Longitudinal Stability). The
goodness of testretest reliability differs according to
whether irritability is measured continuously or categori-
cally. Studies using dimensional approaches show that irri-
tability is moderately stable over time, with correlations
ranging between 0.29 and 0.88.50,52-54 Recently, a study of
2,620 children aged 8 to 9 years followed up for more than 10
years found that both parent- and self-reports of irritability
were moderately correlated over time (r parent, 0.32–0.49;
r self, 0.31–0.45).55
However, as compared with other psychiatric disorders,
the current categorical deﬁnition of irritability shows low
stability across time. DSM-5 ﬁeld trials have shown poor
testretest reliability for DMDD (k ¼ 0.25; 95%
CI ¼ 0.150.36).56 In a clinical sample of children with
DMDD aged 6 to 12 years, only 19% met criteria at 1- and
2-year follow-up.57 Similarly, ﬁndings over 4 time points in
the Great Smoky Mountain study showed that most youth
with SMD (82.5%) met SMD criteria in 1 wave, but only
1.4% met criteria in all 4 waves of assessment.31 However,
ﬁndings on the same sample showed that youth with either
persistent anger or temper outburst had a 75% likelihood of
having either persistent anger or temper outburst 1 year
later.24
Thus, it appears that irritability deﬁned stringently and
categorically remains chronic only in a small proportion of
children. The lack of stability of categorically deﬁned irrita-
bility is probably because a particular, artiﬁcially set
threshold is not met: for example, thresholds that stipulate
the frequency of temper outbursts or duration of negative
mood. Therefore, a high proportion of children who do not
meet current DMDD criteria still present with impairing
chronic irritability.58 Recently, a study evaluated only the
main symptoms of DMDD (i.e., irritable/angry mood and
temper outburst) in a community sample of children fol-
lowed up for more than 8 years.59 The authors found that
although rates of symptom remission were high (71%), the
prevalence of new cases was also considerable (55%).
Moreover, 29% of the participants with frequent DMDD
symptoms at baseline also displayed these symptoms at
follow-up.59
Interrater Reliability. In a German sample of 1,031 chil-
dren and adolescents aged 10 to 18 years,38 the correlation
between parent and child reports of irritability was r ¼ 0.32,
very similar to the results found in a recent longitudinal
study (r ¼ 0.230.36) with 2,620 Swedish children.55 These 2
studies used items from the CBCL to measure irritability. A
study using a speciﬁc measure of irritability (i.e., the Affec-
tive Reactivity Index) found that parent- and self-report
scales were strongly correlated in both a US sample (r ¼
0.58; 95% CI ¼ 0.47–0.66) and a UK sample (r ¼ 0.73; 95%
CI ¼ 0.56–0.85).50 However, in other samples (Dr. Joel
Stoddard, NIMH, personal communication), correlations
were within the bounds of what one would expect according
to a meta-analysis on cross-informant agreement in behav-
ioral and emotional problems.60
Conclusion: Irritability shows mostly good internal
consistency and substantial longitudinal stability when
measured continuously. Its testretest reliability as the
categorical construct of DMDD is poor, probably because
children may fall just below threshold but still be impaired
by irritability.58 Interrater reliability of irritability, specif-
ically between self- and parent reports,60 is consistent
with the reliability of other behavioral and emotional
constructs.
LONGITUDINAL OUTCOMES
Speciﬁc Question: Does irritability have longitudinal pre-
dictions that differentiate it from other disorders?
A key question is what happens to irritable children
over time. Are interindividual differences in irritability
innocuous, or are they useful in predicting trajectories of
future impairment? Also, is irritability an antecedent of
speciﬁc future problems, or rather a predictor of a broad
array of difﬁculties? To answer these questions, we use a
quantitative approach, that is, a meta-analysis. We also
provide data on future functional outcomes associated with
irritability.
In Supplement 1, available online, we describe in detail
the methods used for the meta-analysis, including data
sources, search strategies, inclusion/exclusion criteria, study
selection, data extraction, and data analysis. Additional an-
alytic steps, such as removing separate studies conducted on
the same sample or attempts to explain heterogeneity and
publication bias, are presented in the main text only if they
inﬂuence the main conclusions; otherwise, they are pre-
sented in the supplemental material.
Brieﬂy, we meta-analyzed longitudinal studies in which
chronic nonepisodic irritability was the predictor of future
psychiatric disorders, as these are most clinically relevant.
We conducted the meta-analysis for ﬁndings where outcome
data from 2 or more studies of different cohorts could be
combined, and then calculated pooled odds ratios (ORs) and
95% CIs for each possible outcome. We also reviewed lon-
gitudinal studies predicting continuous outcomes (i.e.,
symptom scores) or providing descriptive statistics. When
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possible, these studies were subjected to a separate meta-
analysis, and pooled standardized b coefﬁcients and 95%
CIs were calculated. Otherwise, only a description of the
ﬁndings is provided.
When 2 or more studies from the same cohort predicted
the same outcome, each of these studies was individually
excluded from the analysis, and the pooled estimates and
95% CIs were recalculated. If an individual study from a
speciﬁc cohort contributed heavily to the pooled estimate, a
change in the magnitude or signiﬁcance of the pooled esti-
mate would be observed.
We tested for between-study heterogeneity using the
I2 statistic, which is the percentage of variation attributable
to heterogeneity. The values of I2 lie between 0% and
100%, with larger values showing increasing hetero-
geneity. Higgins et al.61 suggest that I2 values between 25%
and 50% are low, between 50% and 75% moderate, and
for 75% high.
Finally, given the possibility of publication bias (i.e.,
signiﬁcant ﬁndings being more likely to be published), we
examined whether there was asymmetry in funnel plots
(a scatterplot of the estimates from individual studies against
a measure of a study size) and calculated the Egger’s coef-
ﬁcient bias.62
Characteristics of Studies for the Meta-Analysis
The search and review of studies resulted in 12 studies
appropriate for inclusion in the meta-analysis for the predic-
tion of psychiatric disorders,19,30,31,35,43,44,49,57,63-66 and 12
studies predicting continuous outcomes37,40,42,46,52,53,67-70 or
appropriate for descriptive analysis58,71 (see Figure S1, avail-
able online). In addition, 5 studies among those included in
the meta-analysis provided information about future func-
tional outcomes,19,30,35,49,63 including suicidal behaviors.
Information about the 12 studies included in the meta-
analysis for the prediction of psychiatric disorders is pre-
sented in Table S1, available online. These studies comprised
9 cohorts and 7,594 unique participants. The analyses
included the prediction of depression, anxiety disorder, BD,
attention-deﬁcit/hyperactivity disorder (ADHD), ODD,
conduct disorder (CD; antisocial personality disorder in
adulthood), and substance disorder.
Below we present the results of the meta-analysis for the
prediction of each disorder. Studies predicting continuous
outcomes are analyzed and described in detail in the
supplemental material, available online, and only the main
results of those studies are described here. Results from
studies predicting functional impairment are described in a
separate section at the end.
Chronic Irritability as a Predictor of Psychiatric Disorders
Figure 2 shows effect sizes and the corresponding 95% CIs
for each study in the prediction of future psychiatric disor-
ders from irritability. Results are presented for each psy-
chiatric disorder separately.
Depressive Disorder. Ten studies representing 7 cohorts
included depressive disorder as an outcome. Of those 10
studies, 8 reported signiﬁcant ﬁndings, with irritability
predicting depression at follow-up (OR ¼ 1.80, 95%
CI ¼ 1.422.27, p < 0.001). The overall variance of these
results was moderate (I2 ¼ 56.7%), suggesting that 57% of
heterogeneity was due to covariates.
Anxiety Disorders. Ten studies representing 7 cohorts
included anxiety disorder as an outcome. Irritability was a
signiﬁcant predictor of anxiety at follow-up (OR ¼ 1.72, 95%
CI ¼ 1.312.26, p  .001). The overall variance of these re-
sults was also moderate (I2 ¼ 54.9).
Bipolar Disorder. Three studies representing 2 cohorts
included BD as the outcome. No study reported signiﬁcant
ﬁndings. When all of these studies were considered together,
chronic irritability was not a signiﬁcant predictor of BD at
follow-up (OR ¼ 1.09, 95% CI ¼ 0.671.77, p ¼ .739). The
overall variance of these results was low (I2 ¼ 0%).
Conduct Disorder. Seven studies representing 5 cohorts
included CD as an outcome. Of those, no study reported
signiﬁcant ﬁndings. When all of these studies were consid-
ered together, irritability was not a signiﬁcant predictor of
CD at follow-up (OR ¼ 1.04, 95% CI ¼ 0.831.30, p ¼ .735).
The overall variance of these results was low (I2 ¼ 7.2%).
ADHD. Six studies representing 6 different cohorts
included ADHD as outcome. Of those, only 1 study reported
signiﬁcant ﬁndings.64 When all the studies were considered
together, irritability was not a signiﬁcant predictor of ADHD
at follow-up (OR ¼ 1.25, 95% CI ¼ 0.931.68, p ¼ .139). The
overall variance of these results was low (I2 ¼ 0%).
ODD. Six studies representing 5 cohorts included ODD
as an outcome. When all of the studies were considered
together, irritability was a signiﬁcant predictor of ODD at
follow-up (OR ¼ 2.62, 95% CI ¼ 1.414.85, p ¼ .002).
However, the overall variance of these results was high
(I2 ¼ 83.2). It should be noted that this association is very
likely to have been inﬂated by item overlap.
Substance Abuse/Dependence. Four studies representing 2
cohorts included substance disorder as an outcome. Of
those, no study reported signiﬁcant ﬁndings. When all of the
studies were considered together, irritability was not a sig-
niﬁcant predictor of drug abuse at follow-up (OR ¼ 1.11,
95% CI ¼ 0.741.65, p ¼ .613). The overall variance of these
results was low (I2 ¼ 27.2%).
Test of publication bias was examined only for the pre-
diction of depression and anxiety, as these were the only
outcomes with 10 studies, which is the minimum number of
studies recommended for test of publication bias.72 For anx-
iety, there was no evidence of publication bias. For depres-
sion, the Egger bias coefﬁcient suggested the presence of
asymmetry and publication bias (bias ¼ 2.60, p ¼ .004)
toward positive results, but this asymmetry was accounted
for by 2 studies30,31 and disappeared when these 2 studies
were removed from the analyses (OR ¼ 1.61, 95%
CI¼ 1.351.93, p¼ .076, I2¼ 34.6%; bias¼ 2.21, p¼ .067) (see
Figures S2 and S3, available online). Most of the remaining
individual effect estimates were greater than 1; therefore, the
effect of publication bias, if any, would be to inﬂate the esti-
mate rather than to lead to an incorrect conclusion about the
existence of an effect. Test of publication bias in the prediction
of the remaining outcomes (although these included fewer
than 10 studies) yielded nonsigniﬁcant results. A detailed
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description of examination of publication bias is provided in
the supplemental material, available online.
Prediction of Continuous Outcomes
Information about the 12 studies predicting continuous
outcomes or appropriate for descriptive review is presented
in Table S2, available online. Consistent with the results for
categorical outcomes, studies using continuous outcomes
(i.e., symptom scores) found that irritability is associated
with future depression37,42,46,52,67,68,70 and internalizing
symptoms (i.e. depression and anxiety together),40,53,64,69
with pooled effect sizes (ES) ranging from 0.12 to 0.21
(p < .001) (see supplemental material, available online).
Prediction of Functional Outcomes
Irritability in youth has been associated with lower ﬁnancial
and educational attainment19,30 as well as worse health
outcomes in adulthood.30 The association between irritabil-
ity and future functional impairment has also been found in
preschool children.49,63 Finally, 1 study found that irritability
in adolescence was associated with suicidal behaviors in
FIGURE 2 Forest plot of irritability as a predictor of future psychiatric disorders. Note: Points represent the estimated odds ratio of
each study; the lines bisecting the point correspond to the 95% CI. Pooled effect sizes are represented by diamonds. Weights for each
study are given in the far-right column. ADHD ¼ attention-deficit/hyperactivity disorder; ODD ¼ oppositional defiant disorder.
NOTE: Weights are from random effects analysis
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adulthood independent of affective diagnoses (OR ¼ 3.2;
95% CI ¼ 1.9–5.3; p < .001).35
Exploratory analyses of covariates that could explain the
variability of effect sizes for the prediction of depression,
anxiety, and ODD were not signiﬁcant. A detailed descrip-
tion of these analyses can be found in the supplemental
material, available online.
Conclusion: Irritability is associated speciﬁcally with
future depression and anxiety problems. In addition, irrita-
bility appears to be associated with future impairment, even
when adjusting for baseline psychopathology.
ETIOLOGICAL UNDERPINNINGS
Speciﬁc Question: Comparing irritability with other psychi-
atric traits, what shared and distinct pathophysiological
mechanisms can be discerned?
At least since the work of Robins and Guze,17 attempts
have been made to validate psychiatric disorders by
showing distinct pathophysiology, such as genetics or brain
physiology. Thus far, this has proved difﬁcult to achieve for
common psychiatric disorders, such as depression, anxiety,
or schizophrenia. Irritability—deﬁned either as a trait, as
SMD or as DMDD—is no exception. In this section, we
present evidence from genetics and neuroimaging, mainly
because the vast majority of etiological studies come under 1
of these headings.
Genetically Informative and Family Studies
Twin studies seek to estimate the heritability of a trait (i.e.,
irritability) by comparing the phenotypic (e.g., behavioral,
emotional) similarity of monozygotic twins, who are genet-
ically identical, with that of dizygotic twins, who share on
average 50% of their genes. These studies also allow us to
decompose the observed variance of a trait into its genetic,
shared environmental, and nonshared environmental com-
ponents. Shared environmental factors are those environ-
mental inﬂuences that cause siblings in the same family to be
similar to one another (e.g., growing up in the same neigh-
borhood, the family’s socioeconomic status), whereas non-
shared environment factors are environmental inﬂuences
that cause siblings in the same family to be different from
one another (e.g., having different friends, experiencing
different life events).73
Heritability. The genetic contribution to the variation of
irritability is approximately 30% to 40% in both adults74 and
adolescents.37 This is close to the heritability estimates for
depression and anxiety.75 Genetic inﬂuences on irritability
increase slightly over time in males and decrease in females,55
and unique (as opposed to shared) environmental factors
explain most of the remaining (non-genetic) variance in both.
Family History. A family history of depression has been
associated with the ODD irritability dimension,41 and
maternal depression predicts irritability in young children.76
In addition, the relation between maternal history of
depression and adolescent depression is mediated partly by
the presence of irritability in childhood.70 Although one
study showed no differences in parental history of psychi-
atric disorders between youth with and without DMDD,57
parents of youth with narrow BD were more likely to be
diagnosed with BD than parents of youth with SMD.77
Overlap Between Irritability and Depression. A twin genetic
study showed that irritability and depression share sub-
stantial genetic variance,37 that is, the longitudinal associa-
tion between irritability and depression is, to a signiﬁcant
extent, due to overlapping genetic factors. By contrast, irri-
tability and depression differ phenotypically because of
unique environmental factors. This ﬁnding is in keeping
with what is known from other psychiatric phenotypes, such
as depression and anxiety.78
Recently, a longitudinal study found that genetic
covariance between irritability and anxiety/depression is
highest in early adolescence (74%), and that the impact of
irritability on future internalizing symptoms is higher than
the impact of internalizing symptoms on future irritability.69
Neurocognitive Mechanisms
Research on behavioral and neurobiological mechanisms in
irritability has recently started to emerge. To date, most of
this research has focused on differentiating SMD from BD
and healthy volunteers (HV)20 and, to lesser extent, from
ADHD79,80 and depression/anxiety.80 Here, we present the
main ﬁndings in behavioral experiments and structural and
functional imaging studies.
Behavioral Results. Three main behavioral ﬁndings have
been reported in youth with SMD. First, young people with
chronic severe irritability show face emotion labeling deﬁcits
across emotions.80-82 This abnormality is not unique to
children with irritability but is also seen in youth with BD83
and other psychopathology.84 Second, youth with SMD
show aberrant face emotion threat processing, as evidenced
by showing attentional bias toward threatening faces85 and
by perceiving neutral faces as more threatening79 than do
HV. Bias toward threatening faces has also been found in
irritable children from a community sample (unpublished
data, October 2015). In addition, a recent study found that
youth with DMDD rated ambiguous faces as more angry
than did HV.86 The bias toward threatening faces is not
unique to SMD but is also present in people with depression
and anxiety.87,88
Finally, compared with HV, youth with SMD have deﬁ-
cits in reversal learning,89 performing even worse than youth
with BD when attentional demands increase.89
Structural Neuroimaging. To our knowledge, there is only
one study on structural magnetic resonance imaging (MRI)
examining differences among youth with SMD, youth with
BD, and HV.90 Cross-sectional ﬁndings revealed that,
compared with HV, youth with SMD and BD had greater
gray matter volume in the presupplementary motor area,
dorsolateral prefrontal cortex, and insula. However, abnor-
mally increased parietal and precuneus volume was seen
only in participants with BD,90 suggesting that SMD and BD
may differ in structural brain development.
Functional Neuroimaging. Overall, two main deﬁcits have
been associated with SMD: namely, alterations in the pro-
cessing of emotional stimuli, and alterations in adapting to
changing environments.
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Processing of Emotional Stimuli. Functional MRI (fMRI)
paradigms examining face emotion processing can probe
conscious processing of face emotions (i.e., unmasked faces
presented for 40 milliseconds) or nonconscious (i.e.,
masked faces presented for <40 milliseconds). Unmasked
processing can be implicit, in which research participants
focus on a stimulus feature other than the face emotion (e.g.,
reporting nose width or gender), or explicit, in which the
task directs attention toward the face emotion (e.g., rating
fear or hostility). Finally, there are also affective priming
paradigms, in which the response to a neutral stimulus is
inﬂuenced by the previous presentation (either masked or
unmasked) of an emotional face.
To date, research ﬁndings suggest that youth with SMD
display amygdala dysfunction. Early evidence suggests that
amygdala hypoactivity may be present during explicit pro-
cessing of face emotions,79 while amygadala hyperactivity is
evident during implicit processing, compared to that in
HV79,91 as well as to youth with BD or ADHD.79 In addition, 1
study combining explicit and implicit processing found inap-
propriate modulation of amygdala activity with increasing
anger in faces in youth with SMD compared with HV,92 again
supporting an amygdala dysfunction hypothesis in SMD.
Two studies using affective priming tasks with both
masked and unmasked emotional faces93,94 found that youth
with SMD show higher activation during viewing of angry
faces in the posterior cingulate and superior temporal gyrus
compared to HV.93,94 One of these studies also found
hyperactivation in the insula, parahippocampal gyrus, and
thalamus in the same contrast, and the same regions showed
hypoactivation when processing happy faces.94 In contrast,
compared to BD, youth with SMD show lower activity in
parietal, temporal, and frontal regions when processing
neutral faces.93
Aberrant response to emotional stimuli in the amygdala
and frontal regions is consistent with recent ﬁndings in
functional connectivity during resting state fMRI.95 In this
study, youth with BD showed higher functional connectivity
between the left basolateral amygdala and the medial su-
perior gyrus and posterior cingulate than participants with
SMD.95
Ability to Adapt to Changing Environments. The capacity to
adapt behavior in response to changes in environmental
contingencies (e.g., when progress toward a goal is blocked)
is called context-dependent regulation. In experimental set-
tings, 2 paradigms have been used to assess this adaptive
ability: reversal learning paradigms, in which the rewarded
object (A versus B) changes continuously and the individual
must detect the change in reward contingencies; and frus-
tration paradigms, in which frustration is induced by
changing reward contingencies so that participants are un-
able to attain a desired reward.
During a response reversal task, the difference in activa-
tion between correct and incorrect trials was smaller in
youth with SMD compared to HV in the caudate, and
smaller in the inferior frontal gyrus compared to both HV
and BD.96 These regions are involved in learning from error
signals and response inhibition, respectively, suggesting that
youth with SMD have difﬁculties learning from errors and
changing their behaviors accordingly. Differences between
youth with SMD and BD were also shown in motor inhibi-
tion tasks, in which participants with BD showed less acti-
vation than youth with SMD and HV in the anterior
cingulate cortex (ACC) and nucleus accumbens (NAcc)
during failed inhibition.97
Few studies have used frustration paradigms in youth
with severe irritability. These have shown that, under frus-
trating conditions, youth with SMD display aberrant
amygdala, striatal, parietal, and posterior cingulate activa-
tions compared with HV,98,99 suggesting difﬁculties in
emotion regulation, reward processing, and attentional
control. Moreover, youth with SMD differ from those with
BD in their event-related potentials (ERPs)100 and brain
activation patterns101 during frustration. The pattern of ERPs
following frustration suggested impaired early attentional
processes in youth with SMD compared with HV and those
with BD, with alterations in frontal and temporal regions.100
Aberrant frontal activations, including those in the ACC and
medial frontal gyrus, were also found in youth with SMD in
response to negative feedback compared with HV, whereas
youth with BD presented with decreased activation in the
superior frontal gyrus and insula.101
Correlations With Irritability. Reports of associations be-
tween brain activations and dimensionally measured irrita-
bility are scarce. In preschool children with severe chronic
irritability, higher levels of parent-reported irritability were
negatively associated with ACC activation99 and positively
associated with dorsolateral prefrontal cortex (PFC) activa-
tion102 during a frustration task. By contrast, in youth with
SMD, parent- or child-reported irritability was negatively
correlated with activation in the right thalamus during
processing of happy faces and positively correlated with
activation in the left ventromedial PFC during nonaware
perception of emotional faces.94
Conclusion: Irritability is moderately heritable. Genetic
factors underlie the phenotypic overlap between irritability
and depression—indicating the shared etiology between the
2 disorders—although it remains unclear which genes are
involved. Thus, similar to other psychiatric disorders, what
makes irritability unique from depression are environmental
factors (although it is unclear what these factors are). By
contrast, genetic factors seem to be pleiotropic and mediate
the overlap between irritability and other traits, very much
in keeping with the current understanding that psychiatric
disorders are comorbid with each other due to shared
genes.103
Youth with SMD share aberrant processing with BD but
also differ in functional and structural MRI ﬁndings. Overall,
youth with SMD compared to healthy volunteers show
altered activations in amygdala (emotional processing),
striatum (reward processing and error learning), and frontal
regions (attention, inhibition/cognitive control, alternative
response).
TREATMENT RESPONSE
Speciﬁc Questions: What are the most effective treatments for
irritability? Can treatment tell us anything about the
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pathophysiology of irritability? Are there treatments that are
speciﬁc to irritability?
Drawing etiological inferences from treatment response
(ex juvantibus) is common in other areas of medicine, such
as infectious diseases.104 Yet, in psychiatry, many different
disorders may respond to the same treatment—for example,
antipsychotics are useful in both schizophrenia and BD, and
antidepressants can be effective in both depression and
anxiety disorders. This might also be the case with irrita-
bility, for which so far there is no speciﬁc treatment and
which may respond to a range of treatments.
To our knowledge, there is only 1 published RCT specif-
ically treating irritability,105 which found no beneﬁt of lithium
over placebo in children with SMD. This was another
important step in differentiating chronic irritability from
mania. The only other published pharmacological study to
have irritability as a primary outcome is a non-RCT open-
label trial that used low doses of risperidone in youth with
SMD and showed signiﬁcant reductions in irritability scores.106
Irritability may respond to stimulant medication, at least
in the context of ADHD. Recently, post hoc analyses in the
Multimodal Treatment Study of Children with ADHD (MTA
Study) found that stimulant (ES ¼ 0.63) or stimulant plus
behavioral treatment (ES ¼ 0.82) was better than behavioral
treatment alone (ES ¼ 0.42) in reducing irritability symp-
toms.107 However, the magnitude of the effect sizes for the
irritability response to treatment was approximately half of
that for ADHD symptoms.108 These recent ﬁndings are
consistent with results from studies of a related phenotype,
aggression (i.e., 2 meta-analyses show moderate to large ES
for stimulant treatment of aggression in ADHD109,110). In
addition, 1 study111 found that stimulants along with
behavioral therapy reduced externalizing symptoms in
children with ADHD and SMD. Moreover, a recent meta-
analysis found that emotional instability in ADHD
beneﬁted from stimulants.112 Finally, the mood stabilizer
divalproex added to stimulant has shown to be effective in
children who remain aggressive despite optimized treatment
of ADHD symptoms.113 It remains unclear, however,
whether stimulants treat irritability directly or by decreasing
ADHD symptoms ﬁrst.
There is indirect evidence from the adult literature that
selective serotonin reuptake inhibitors (SSRIs) may be
effective in the treatment of irritability, aggression, and
explosive outbursts in the context of mood disorders
(depression, dysthymic disorder, premenstrual syndrome, or
anxiety)114,115 and intermittent explosive disorder.116 How-
ever, none of these trials has targeted irritability in itself.
Trials of SSRIs following a stimulant lead-in phase are
ongoing at the National Institute of Mental Health (NIMH)
and University of California, Los Angeles (UCLA), but no
other research in young people has been published.
Antipsychotics may be effective in decreasing irritability
and aggression in children with sub-average IQ117 and
autism spectrum disorders (ASD).118,119 However, the extent
to which irritability in those trials (typically measured by
observation using the Aberrant Behavior Checklist) corre-
sponds to irritability as deﬁned in most studies quoted in
this article remains unclear.120
For psychological interventions, parent training may be
effective in reducing irritability in children with ODD121 and
ASD.122 In addition, individual cognitive-behavioral therapy
(CBT) has demonstrated effectiveness in youth with exces-
sive anger123 and Tourette syndrome.124 Individual CBT also
reduced temper outbursts in a clinical sample of young
people with OCD and depressive symptoms,125 but this was
not a trial design. Group CBT has been shown to be effective
in 1 trial of youth with ADHD plus SMD.126,127
Recently, and based on the work of Penton-Voak
et al.,128,129 Stoddard et al.86 tested whether the judgment
of ambiguous faces as angry could be altered in youth with
DMDD, and whether this change might be associated with
reduced irritability. Using an open active training, the au-
thors showed that the bias was reduced, as well as levels of
irritability, and that this reduction was associated with
changes in neural activity in the orbitofrontal cortex (OFC)
and amygdala.86
Conclusion: Very few trials have been conducted with ir-
ritability as a primary outcome. Most knowledge about the
treatment of irritability is based on effects of treatment on
related conditions (e.g., aggression or ODD), or through post
hoc analyses of trial data (e.g., irritability in those
with ADHD).
DISCUSSION
The main aim of this review was to assess the status of ir-
ritability in nosology by examining whether irritability is a
reliable and valid construct. Using a combination of selective
and systematic reviewing as well as a meta-analysis, we
found that irritability can be measured reliably and that it
forms a distinguishable factor with distinct longitudinal
predictions. This is particularly evident for irritability as a
dimensional construct, which shows reliability and predic-
tive value that is comparable to that in other psychiatric
entities, such as anxiety or hyperactivity. Moreover, we
showed that irritability is a robust predictor of future
emotional disorders, particularly depression, as well as of
overall social role impairment.
These ﬁndings are particularly relevant as it had been
claimed that irritability is to psychopathology what fever is
to general medicine.130 This analogy may not apply for 2
reasons. First, in contrast to fever, irritability does not seem
to be simply the generic expression of different types of
problems, but to be related differentially to depression and
anxiety in longitudinal and genetic studies. Second, irrita-
bility appears to be associated with future impairment even
when adjusting for concurrent psychopathology, suggesting
that, unlike most cases of pyrexia, it may have long-lasting
consequences. However, it is clear that much work is
required to better understand the position of irritability in
nosology. Below we provide an outline of what we consider
to be important next steps in the ﬁeld.
Measurement
Probably the main limitation in the study and treatment of
irritability so far is the lack of high-quality measures. Most of
the measurement of irritability has been done with
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instruments created ad hoc, that is, through extracting items
from existing scales or interviews that were not intended
primarily to measure irritability. This was an understand-
able approach, as it allowed researchers to exploit existing
data. However, this approach risks overlooking important
aspects of the phenotype in question, or measuring it with
problematic reliability and validity, thereby reducing the
signal-to-noise ratio. Future studies should make use of
existing instruments speciﬁcally designed to capture irrita-
bility or develop new measures. To facilitate thinking about
new approaches to measurement, we break down the sec-
tion into different domains.
Questionnaires. Although it was not a measure specif-
ically designed to capture irritability, the Multidimensional
Assessment of Preschool Disruptive Behavior (MAP-DB)
Questionnaire is a valid instrument to assess irritability
features in preschool children. The MAP-DB Temper Loss
subscale contains 20 items that assess several features of
tantrums and anger regulation with good internal consis-
tency (a ¼ 0.97), providing a broad coverage of behaviors.131
The recently developed Affective Reactivity Index (ARI) is a
concise way of capturing irritability with data on reliability
and validity for both parent- and self-reported scales.50 It is
short by design so as to allow busy clinicians to measure
irritability in their patients and to be appropriate for use in
large studies, in which participants are often asked several
dozens to hundreds of questions. It allows dimensional
measurement of irritability and is now being used in
mechanistic studies, including brain imaging.94 However,
researchers interested in systematically eliciting information
about either speciﬁc symptoms related to irritability (e.g.,
angry rumination or examples of aggression), or in exam-
ining environmental inﬂuences (context of outbursts, inter-
personal relationships) on irritability, will need to create new
and possibly longer measures.
Change-Sensitive Measures. It is important to create in-
terviews and questionnaires that are sensitive to change to
monitor treatment outcomes, similar to what exists for OCD
(Children’s YaleBrown Obsessive Compulsive Scale) and
depression (Children’s Depression Rating Scale). Parent-,
self-, and clinician-reported versions of the ARI are currently
being tested for this, and other measures should also be
encouraged and tested in view of the need for treatment
studies.
Observational Measures. Systematic observation can be
used to capture behavioral aspects of irritability. This can
include automated coding of facial expressions (FACS) using
machine learning techniques. These measures have been
shown to detect anxiety expressions in youth with ASD
during stressful situations (unpublished data, August, 2015).
Finally, it is imperative to examine irritability using both
multi-informant and multi-method studies. First, few studies
have examined interrater reliability between parent and
self reports,38,55 and only one study has done so using an
irritability measure.50 New instruments, including ques-
tionnaires and interviews, should incorporate different ver-
sions for parent and child. In addition, little is known about
how teachers rate irritability. Second, the assessment of ir-
ritability can include other modalities of measurement, such
as physiological (i.e., heart rate or skin conductance),
biological (i.e., levels of cortisol),120 behavioral (i.e., eye-
tracking), neurological (i.e., fMRI), and day-to-day moni-
toring using digital technology.
Experimental Paradigms. Reviews of paradigms designed
to elicit changes in cortisol as a consequence of negative
emotions such as fear or anger show that a substantial
proportion of young people display no evidence of expe-
riencing the stimulus as a stress challenge unless the task
also evokes negative self-referent emotions such as shame
and public exposure.132,133 This probably also applies to
anger-induction methods: those that include social expo-
sure (i.e., the participant feels that he or she is being eval-
uated and compared with peers) and harassment (i.e.,
making negative comments about the participant’s task
performance) appear more powerful in inducing self-
reported anger and associated physiological responses.134
This complexity needs to be borne in mind when
designing future anger induction tasks.
As mentioned in the introductory section of this article,
the Research Domain Criteria’s frustrative nonreward may
prove a very useful concept for the experimental study of
irritability.12,98 The basic concept is that of blocked goal
attainment, or of the absence or delay of reinforcement,135
something that is readily manipulable in an experimental
setup. This conceptual approach should appeal to clini-
cians who observe a child’s outburst when he or she is not
given what he or she has been given to expect from parents
or peers. However, frustrative nonreward in its own
right may not be sufﬁcient to explain why the proneness
to anger persists beyond the speciﬁc events of blocked
goal attainment. For this, further processes of instru-
mental learning will need to be investigated. More gener-
ally, there is good theoretical background136,137 and
emerging empirical evidence98 for investigating anger
and irritability within a reward framework. This has been
a fruitful strategy in depression research,138 and informs
the broader ﬁeld of behavioural neuroeconomics and
decision making.139
Treatment. To date, there is only 1 RCT of medication for
children with SMD. No pharmacological studies have been
done to examine the treatment outcomes of children with
DMDD, which is understandable, given that it was only
recently introduced. So far, evidence shows that irritability
and anger respond to different treatments within the context
of different disorders; for example, irritability responds to
stimulants intended to treat hyperactivity and inattention in
children with ADHD, and irritability also seems to respond to
exposure treatment for anxiety in children with OCD. How-
ever, irritability was not the primary outcome in many
studies, and some results are extracted from post hoc analyses
of available data. The observation that many different treat-
ments primarily used for other disorders appear to beneﬁt
moderately those with irritability can have 2 explanations.
First, treatments such as stimulants may target a set of
mechanisms that are generic and part of various different
disorders. Second, irritability may improve because it is sec-
ondary to the disorder being treated; for example, once
ADHD symptoms improve, irritability may also reduce. As
JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 55 NUMBER 7 JULY 2016 www.jaacap.org 565
IRRITABILITY IN PSYCHIATRY: A CONCEPTUAL AND QUANTITATIVE REVIEW
mentioned above, validating instruments for the sensitive
measurement of change will be a crucial step toward
designing better treatment studies with irritability as primary
outcome. In addition, given the nonspeciﬁc response of irri-
tability to different treatments in the context of distinct dis-
orders, future studies must examine whether these treatments
inﬂuence irritability before, at the same time, or after symp-
toms of the primary disorder.
It is an obvious aim to test parenting interventions—
which are known to be useful in ODD140—in irritability.
More generally, the role of parent–child relationships in the
development of irritability and the possible protective effects
of parental appraisals141 should be tested.
Validity. We systematically reviewed data on the validity
of the irritability construct based on factor analyses, longi-
tudinal stability and consistency, longitudinal correlates,
and etiological underpinnings. Although evidence to date
allows us to draw some conclusions, these are limited for
several reasons.
First, factor and latent class analyses have been con-
ducted within a narrow set of items usually derived post hoc
(mainly by using ODD symptom measures). These analyses
should be replicated using a larger set of variables including
more irritability variables, ideally as part of well-validated
instruments, and items assessing symptoms from other
psychiatric disorders (e.g. ADHD or depression symptoms).
In addition, multivariate studies show that the correlation
between the ODD dimensions of irritability and headstrong
ranges from moderate38,40,142,143 to high.36 Understanding
the causes of such variation will be important to disentangle
the unique and generic pathophysiological factors contrib-
uting to irritability.
Second, our review and meta-analysis of longitudinal
correlates of irritability pointed toward depression and
anxiety as its main future correlates. However, there was
heterogeneity among studies. Although most studies used
dimensional measures of irritability, some studies used cat-
egorical deﬁnitions.30,31,57 Moreover, instruments used to
measure irritability differed between studies. In addition,
only some studies adjusted analyses for the presence of
headstrong/hurtful symptoms, which is important given the
high correlations between these dimensions. Studies also
differed in adjustments for baseline psychopathology, de-
mographic factors such as sex and age, or socioeconomic
status. Despite these differences, however, analyses of sub-
groups and meta-regressions did not yield signiﬁcant re-
sults. We were able to test for publication bias only in
anxiety and depression due to the low number of studies in
the other domains. We did not ﬁnd evidence for publication
bias in anxiety. In depression, there was weak evidence for
publication bias, which is probably best explained by the
heterogeneity of the studies included. Indeed, after two
studies contributing to heterogeneity were excluded, there
was no longer evidence of bias. Finally, most studies
examining longitudinal correlates included depression as an
outcome, but very few included BD, conduct problems, and
substance abuse. For future research, more studies predict-
ing several outcomes, using different cohorts, and deriving
from independent research groups are needed.
Regarding etiological underpinnings, there is evidence on
the heritability of irritability, yet there are very few studies
addressing its genetic association with other disorders,
especially other than depression.37,69
Behavioral and neuroimaging research on chronic irrita-
bility is a newly emerging ﬁeld. Mapping between behav-
ioral and imaging ﬁndings is still outstanding, and so far
only 1 published neuroimaging study has used continuous
measures of irritability.94 In some studies, it has been difﬁ-
cult to separate the effects of ODD or ADHD on irritability
ﬁndings because of high comorbidity with SMD. Moreover,
behavioral and neuroimaging studies have focused on
differentiating SMD from BD. It is imperative to include
other comparison groups such as depression, anxiety, ODD,
ADHD, or ASD to examine their shared and distinct un-
derpinnings. The developmental pathway from irritability to
depression and their genetic overlap is one of the main
ﬁndings in this review. This should prompt future neuro-
biological studies that examine the possible substrates for
this overlap by testing experimental paradigms that incor-
porate transitions between cardinal emotions such as anger
and sadness, for example.
In this review, we have not separately analyzed DMDD
and SMD, as doing so would lead to very small groups to
analyze with validity. It is important to note that the vast
majority of youth with SMD meet criteria for DMDD. For
example, in a report by Deveney et al.,58 of the 200 youth
who met criteria for SMD, 97% met criteria for DMDD; the 6
youth who did not meet criteria for DMDD had an age of
onset of 10 or 11 years old. Similarly, in a report by Stoddard
et al.,95 all but 1 youth with SMD met criteria for DMDD. It
therefore seems reasonable to pool these 2 diagnoses in our
analyses. Also, following the current conceptualization of
psychiatric disorders as extremes of dimensional traits,16 we
regard DMDD and SMD as lying above a certain threshold
on an irritability continuum. This is an assumption sup-
ported by prior data on irritability,131 although not DMDD
or SMD as such. Future research should test the validity of
that assumption also in terms of underlying pathophysio-
logical mechanisms. &
Clinical Guidance
 Our review showed that irritability is impairing for young
people and that it is associated with a substantially
increased likelihood of future psychopathology,
particularly depression and anxiety.
 In understanding how irritability arises and when it
becomes pathological, a lot has been accomplished
within a short period of time. However, a number of
areas—most notably measurement and experimental
design—still require research attention.
 Clinicians will want to measure irritability in their patients
as outlined in this review and apply the—admittedly still
scarce—evidence in treating it.
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